Lu, Mijia
Zhang, Zijie
Xue, Miaoge
Zhao, Boxuan Simen
Harder, Olivia
Li, Anzhong
Liang, Xueya
Gao, Thomas Z.
Xu, Yunsheng
Zhou, Jiyong
Feng, Zongdi
Niewiesk, Stefan
Peeples, Mark E.
He, Chuan http://orcid.org/0000-0003-4319-7424
Li, Jianrong http://orcid.org/0000-0002-7130-1084
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AI112524, AI112524, HG008688, HG008935)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI090060, AI112524)
Article History
Received: 31 January 2019
Accepted: 3 December 2019
First Online: 3 February 2020
Competing interests
: C.H. is a scientific founder of Accent Therapeutics. J.L., C.H., M.E.P. and S.N. have filed a provisional patent application (no. 62/748,175).